XML 19 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating Activities    
Net Income $ 340 $ 291
Adjustments to reconcile Net Income to Net cash and cash equivalents from operating activities:    
Depreciation and amortization 191 156
Stock-based compensation 19 17
Amortization of operating lease right-of-use assets 13 13
Deferred income taxes 99 78
Earnings from equity method investees (101) (125)
Dividends from equity method investees 105 123
Loss from financing activities 0 4
Changes in assets and liabilities:    
Accounts receivable, net (13) 16
Accounts payable (15) 6
Interest payable 37 28
Contract liabilities 23 16
Other current and noncurrent assets and liabilities 8 (12)
Net cash and cash equivalents from operating activities 706 611
Investing Activities    
Plant and equipment expenditures (295) (260)
Acquisition accounted for as a business combination (purchase price adjustment) 10 0
Distributions from equity method investees 34 467
Contributions to equity method investees (3) (4)
Net cash and cash equivalents from (used for) investing activities (254) 203
Financing Activities    
Repayment of long-term debt 0 (399)
Borrowings under the Revolving Credit Facility 235 195
Repayment of borrowings under the Revolving Credit Facility (385) (360)
Distributions to noncontrolling interests (14) (14)
Contributions from noncontrolling interests 7 1
Dividends paid on common stock (241) (209)
Other financing activities (24) (7)
Net cash and cash equivalents used for financing activities (422) (793)
Net Increase in Cash and Cash Equivalents 30 21
Cash and Cash Equivalents at Beginning of Period 68 56
Cash and Cash Equivalents at End of Period 98 77
Cash paid for:    
Interest, net of interest capitalized 75 80
Income taxes, net of refunds received 3 7
Supplemental disclosure of non-cash investing and financing activities    
Plant and equipment expenditures in accounts payable and other accrued liabilities $ 83 $ 47